Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass

NCT01373216 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Decreased Left Ventricular Function

Interventions

DRUG: Exenatide

Sponsor

Charles University, Czech Republic

Collaborators

[object Object]